Dalgaard LT

ORCID: 0000-0002-3598-2775 · 5 papers in corpus · active 2016-2025
2025
PloS one ·doi:10.1371/journal.pone.0323529

AimOvarian cancer (OC) is the leading cause of gynecological cancer deaths. Current biomarkers of OC are not specific or sensitive enough. Extracellular vesicles (EVs), EV surface proteins and their cargo microRNA (miRNA) show potential as …

2023
Biomolecules ·doi:10.3390/biom13050871

In this study, we conducted a systematic review and meta-analysis to summarize and evaluate the global research potential of different circulating miRNAs as an early diagnostic biomarker for OC. A systematic literature search for relevant s…

2023
Cells ·doi:10.3390/cells12070983

BackgroundWomen with polycystic ovary syndrome (PCOS) often change their metabolic profile over time to decrease levels of androgens while often gaining a propensity for the development of the metabolic syndrome. Recent discoveries indicate…

2019
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-019-0478-7

BackgroundWomen with Polycystic Ovary Syndrome (PCOS) present a heterogeneous reproductive and metabolic profile with an increased lifetime risk of Type 2 Diabetes (T2D). Early biomarkers of these metabolic disturbances in PCOS women have n…

2016
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2015-3588

ContextPolycystic ovary syndrome (PCOS) has a largely unknown etiology and presents with a clinical heterogeneous patient group. Small noncoding microRNA (miRNA) might prove promising as biomarker candidates for PCOS patient stratification.…